Financhill
Back

Invesco Pharmaceuticals ETF Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
25

PJP
Invesco Pharmaceuticals ETF

Last Price:
86.40
Seasonality Move:
5.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

Invesco Pharmaceuticals ETF Price Quote

$86.40
+0.14 (+-0.06%)
(Updated: November 5, 2024 at 5:38 AM ET)

Invesco Pharmaceuticals ETF Key Stats

Sell
25
Invesco Pharmaceuticals ETF (PJP) is a Sell

Day range:
$86.26 - $86.73
52-week range:
$67.75 - $89.34
Dividend yield:
0.9%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
4.9K
Avg. volume:
7.8K
1-year change:
21.42%
Market cap:
$0
Revenue:
$0
EPS:
$0

How Much Does Invesco Pharmaceuticals ETF Make?

Data Unavailable

Is Invesco Pharmaceuticals ETF Growing As A Company?

Data Unavailable

Invesco Pharmaceuticals ETF Stock Price Performance

What Is Invesco Pharmaceuticals ETF 52-Week High & Low?

Invesco Pharmaceuticals ETF Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Invesco Pharmaceuticals ETF?

Data Unavailable

Is Invesco Pharmaceuticals ETF Cash Flow Positive?

Data Unavailable

Invesco Pharmaceuticals ETF Return On Invested Capital

Data Unavailable

Invesco Pharmaceuticals ETF Earnings Date & Stock Price

Invesco Pharmaceuticals ETF Competitors

  • Who Are Invesco Pharmaceuticals ETF's Competitors?
    Below is a list of companies who compete with Invesco Pharmaceuticals ETF or are related in some way:
    • VanEck Biotech ETF (BBH)
    • First Trust Nasdaq Pharmaceuticals ETF (FTXH)
    • iShares US Healthcare Providers ETF (IHF)
    • Invesco Biotechnology & Genome ETF (PBE)
    • Invesco S&P 500® Equal Wt Hlth Care ETF (RSPH)

Invesco Pharmaceuticals ETF Dividend Yield

Invesco Pharmaceuticals ETF Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable